19Jul
19Jul
ZetrOZ Systems Shares Successful Strategies for Managing a Robust Intellectual Property Portfolio
Running a successful medical device company requires deep knowledge of complex and specialized technologies, how to navigate regulatory requirements, and a thoughtful intellectual property (IP) protection strategy. ZetrOZ Systems' Dr. George Lewis, inventor of the sam® soft tissue healing pain relief ultrasound device, shares insights on how effective IP portfolio management can improve organizational efficiency that creates a competitive edge in today's health technology industry. Read more >>
16Jul
The 24 Best Canned Wine Releases of 2022
The canned wine market is being pulled in different directions. One way is chock full of affordable, mass-produced, widely available products of middling quality, often sharing shelf space with ready-to-drink cocktails and hard seltzers. Sales numbers continue to show that canned wines' popularity is growing. Marketing firm Grand View Research reported the canned wine market in 2021 was at $235.7 million in sales and forecasted that the global canned wine market will continue expanding, surpassing $570 million by 2028. Recent...
14Jul
The team will research insulation that incorporates silica aerogel developed by UB researchers, along with plant-based products
A University at Buffalo-led research team will seek to develop eco-friendly insulation materials through a new $2.2 million project funded by the U.S. Department of Energy (DOE). The grant is part of the DOE Advanced Research Projects Agency – Energy (ARPA-E) Harnessing Emissions into Structures Taking Inputs from the Atmosphere (HESTIA) program, which recently announced $39 million in awards to multiple institutions to advance technologies that can transform buildings into net carbon storage structures. The UB-led team will research carbon-storing...
13Jul
Wasabi next-gen cloud storage solution tackles data protection, security and data sovereignty
It may be summer, but cybercrime doesn’t take a vacation. Last year 76% of organizations suffered from a ransomware attack, according to a recent “2022 Data Protection Trends” report. The report also shows that only 19% of companies outsmarted the criminals and recovered their data without paying a penny. It doesn’t state how they managed that feat, but theCUBE may know. During the “Secure Storage Hot Takes” event, theCUBE and Wasabi Technologies Inc. assessed today’s core security themes; data protection,...
10Jul
Regroup Mass Notification Competes in 6th Annual ‘ASTORS’ Awards
Regroup Mass Notification®, which empowers better mass communication to keep people safe and informed during critical and daily events, is delighted to announce its platform has been nominated for the Sixth Consecutive Year in the Annual ‘ASTORS’ Homeland Security Awards Program. Regroup’s easy-to-use system enables administrators to send up to 20,000 voice calls, 65,000 SMS, 100,000 emails, and 540,000 push notifications per minute, rapidly alerting large groups of recipients to danger. Administrators can also expand their reach by distributing messages...
09Jul
The 10 Best Canned Wines of 2022
As time goes the demand for canned wine seems to rise. It saves space, is easy to transport, and doesn’t require any corkscrews or wait for wine glasses to be washed. And the best part is the wine never gets warm. In this article, we will discuss some of the best canned wines From dry red to wines that are crisp with a note of sweetness. There’s something for everyone. Archer Roose Sauvignon Blanc ($59 for 12 cans) - Archer...
08Jul
Myomo Announces Second Quarter Preliminary Revenue and Record Pipeline Additions
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces preliminary second quarter revenue and provides an update on its pipeline entering the third quarter. Revenue for the second quarter of 2022 is expected to be $3.4 million to $3.6 million, an increase of 10% to 16% compared with the second quarter of 2021. Read more >>
08Jul
FDA Grants Orphan Drug Designation to PBI-200 for NTRK Fusion–Positive Solid Tumors
The FDA has granted an orphan drug designation to PBI-200 for the treatment of patients with NTRK fusion–positive solid tumors, including primary and metastatic brain tumors. PBI-200, which is an oral, highly potent and selective inhibitor of TRK kinase, was designed by Pyramid Biosciences to overcome a wide range of on-target resistance mutations that have been observed with first-generation TRK inhibitors. “Oncogenic NTRK gene fusions are found in a broad range of cancers. Orphan designation for drugs in development such...
01Jul